Physician Scientist
Daiichi Sankyo
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Physician Scientist as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:27 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT05338970 · HERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI TherapyDaiichi Sankyo · active not recruiting · Nonsquamous Non-small Cell Lung Cancer, EGFR L858R, EGFR Exon 19 Deletion · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:27 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in non-small cell lung cancer.